- Home
- SILO vs PAVM Comparison
SILO vs PAVM Comparison
Compare SILO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SILO | PAVM |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 7.1M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | SILO | PAVM |
|---|---|---|
| Price | $0.32 | $10.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 106.0K | ★ 3.0M |
| Earning Date | 11-13-2025 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $72,102.00 | $29,000.00 |
| Revenue This Year | $1.86 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.27 | $6.00 |
| 52 Week High | $1.82 | $28.44 |
Technical Indicators
Market Signals| Indicator | SILO | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 35.16 | 66.33 |
| Support Level | $0.27 | $7.47 |
| Resistance Level | $0.38 | $11.30 |
| Average True Range (ATR) | 0.03 | 2.61 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 24.69 | 15.83 |
Price Performance
Historical ComparisonAbout SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.